| Name | Title | Contact Details |
|---|---|---|
Devin Gross |
Chief Executive Officer | Profile |
Neurotrope was formed in October 2012 to develop and market two product platforms, including a non-invasive diagnostic test for Alzheimer's Disease and a drug candidate called bryostatin for the treatment of Alzheimer's Disease, both of which are in the clinical testing stage. Neurotrope was formed for the primary purpose of commercializing certain technologies that were initially developed by Blanchette Rockefeller Neurosciences Institute ("BRNI") and its affiliates, for therapeutic or diagnostic applications for Alzheimer's Disease or other cognitive dysfunctions. These technologies have been under development since 1999 and have been financed through significant funding from a variety of non-investor sources. The Company expects that its first product, the diagnostic test for Alzheimer's Disease, will finish the testing phase of its development in 2015, whereupon the Company will evaluate the feasibility of its commercialization. In addition to bryostatin and the diagnostic test for Alzheimer's Disease, the Company intends to pursue development of two other technology platforms developed by and licensed from BRNI: the first, a platform for transporting drugs into the brain through the "blood-brain-barrier," and the second, a group of drugs for enhancing cognition, mood and alertness for neuropsychiatric conditions.
Nucon International Inc is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Burgess Health Center is committed to improve the quality of life for the people and communities we serve by providing excellent healthcare and exceptional patient experiences.
Integrated Behavioral Health (IBH) provides innovative technology based tools and effective treatments for employee assistance, workers compensation programs, substance abuse and opioid addiction, behavioral health, and wellness management. For over 35 years, IBH serves over 38K employers and supports 10 million employees and their families. With a focus on positive outcomes through clinically validated methods and tools, IBH reduces claims and costs for organizations while improving the lives of its people.
Instem LSS is a Conshohocken, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.